G-proteins (Gi, Go) in the basal ganglia of control and schizophrenic brain
β Scribed by F. Okada; T. J. Crow; G. W. Roberts
- Publisher
- Springer
- Year
- 1990
- Tongue
- English
- Weight
- 519 KB
- Volume
- 79
- Category
- Article
- ISSN
- 1435-1463
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The present study was designed to test whether chronic neuroleptic treatment, which is known to alter both expression and density of dopamine D 2 receptors in striatal regions, has effects upon function and binding level of the cannabinoid CB 1 receptor in the basal ganglia by using receptor autorad
## Introduction: Previous postmortem studies of glutamate receptors and uptake sites have shown decreased d-aspartate (d-asp) (a marker for the high affinity glutamate uptake site) and elevated (+)-5-methyl-10,11-dihydro-5h-dibenzo [a,d]cyclohepten-5,10-imine maleate (mk-801) binding in the putamen
The mechanism of parkinsonian tremor may involve a central oscillator, peripheral feedback to the central nervous system (CNS), or both. The thalamus or the globus pallidus is the most likely site for a central oscillator and would be predicted to generate thalamic tremor-related activity characteri
Degeneration of the nigrostriatal dopaminergic system is the characteristic neuropathological feature of Parkinson's disease and therapy is primarily based on a dopamine replacement strategy. Dopamine has long been recognized to be a key neuromodulator of basal ganglia function, essential for normal